SMTL ID : 7uas.2 (1 other biounit)

Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.81 Å

Oligo State

monomer

Ligands

1 x MBU: (5P)-2-[(S)-cyclopropyl(4-methylpyridin-2-yl)methyl]-5-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-[(2-methyl-1H-imidazol-1-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one(Non-covalent)

MBU.1: 20 residues within 4Å: Chain A: A.26, V.27, S.28, A.44, G.68, I.69, S.70, D.71, D.86, F.112, F.128, P.152, Y.170, K.238, Y.239, C.240, I.241, F.242, I.284, L.300 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:F.112, A:F.128, A:F.128, A:Y.170, A:Y.239, A:F.242, A:I.284, A:I.284 Hydrogen bonds: A:C.240 pi-Stacking: A:F.112, A:F.112, A:Y.170, A:F.242 Halogen bonds: A:V.27

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Teuscher, K.B. et al., Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization. J.Med.Chem. (2022)

Release Date

2022-05-04

Peptides

WD repeat-containing protein 5: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

WD repeat-containing protein 5

Related Entries With Identical Sequence